A new study has revealed that patients with benign prostatic hyperplasia (BPH) carrying prostate cancer a (PCa) risk alleles are a potential target population for PCa screening and follow-up. The study was presented yesterday at the 28th Annual EAU Congress in Milan. The study aimed to evaluate the genetic predisposition of patients with BPH to developing prostate cancer, with findings suggesting that genetic testing may offer a new tool to identify BPH patients ...
View the original article here
This post was made using the Auto Blogging Software from WebMagnates.org This line will not appear when posts are made after activating the software to full version.
